查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420929

人類生長激素市場（給藥途徑：靜脈注射、皮下注射、肌肉注射和口服）- 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

Human Growth Hormone Market (Route of Administration: Intravenous, Subcutaneous, Intramuscular, and Oral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

人類生長激素市場 - 報告範圍

TMR 關於全球人類生長激素市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球人類生長激素的收入2017-2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球人類生長激素市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解人類生長激素市場。

市場概況
2023年市場價值 28億美元
2031 年市場價值 39 億美元
CAGR 3.7%

該報告深入研究了全球人類生長激素市場的競爭格局。全球人類生長激素市場的主要參與者已經確定，並且每位參與者都根據各種屬性進行了分析。公司概況、財務狀況、近期發展和 SWOT 是本報告中介紹的全球人類生長激素市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2023-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依給藥途徑

  • 簡介與定義
  • 主要發現/進展
  • 市值預測：依給藥途徑，2023-2031
    • 靜脈
    • 皮下
    • 肌肉注射
    • 口服
  • 市場吸引力分析：按給藥途徑

第 7 章：全球市場分析與預測：按配銷通路

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按配銷通路，2023-2031
    • 醫院藥房
    • 網路藥房
    • 零售藥房
    • 診所
  • 市場吸引力分析：按配銷通路

第 8 章：全球市場分析與預測：依指標分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依指標分類，2023-2031
    • 生長激素缺乏
    • 特納氏症
    • 特發性身材矮小
    • 普瑞德威利綜合症
    • 其他適應症
  • 市場吸引力分析：依指標分類

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2023-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Merck KGaA
    • Eli Lilly and Company
    • Pfizer Inc
    • Novo Nordisk A/S
    • Ipsen SA
    • Roche Holdings, Inc
    • Anhui Anke Biotechnology (Group) Co., Ltd.
    • Biopartners GmbH
    • GeneScience Pharmaceuticals Co., Ltd.
    • Novartis AG
Product Code: TMRGL16283

Human Growth Hormone Market - Scope of Report

TMR's report on the global human growth hormone market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global human growth hormone market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global human growth hormone market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the human growth hormone market.

Market Snapshot
Market Value in 2023US$ 2.8 Bn
Market Value in 2031US$ 3.9 Bn
CAGR3.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global human growth hormone market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global human growth hormone market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global human growth hormone market.

The report delves into the competitive landscape of the global human growth hormone market. Key players operating in the global human growth hormone market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global human growth hormone market profiled in this report.

Key Questions Answered in Global human growth hormone Market Report:

  • What is the sales/revenue generated by human growth hormone across all regions during the forecast period?
  • What are the opportunities in the global human growth hormone market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Human Growth Hormone Market - Research Objectives and Research Approach

The comprehensive report on the global human growth hormone market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global human growth hormone market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global human growth hormone market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Human Growth Hormone Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Human Growth Hormone Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Mergers & Acquisitions
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Global Human Growth Hormone Market Analysis and Forecast, by Route of Administration

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 6.3.1. Intravenous
    • 6.3.2. Subcutaneous
    • 6.3.3. Intramuscular
    • 6.3.4. Oral
  • 6.4. Market Attractiveness Analysis, by Route of Administration

7. Global Human Growth Hormone Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2023-2031
    • 7.3.1. Hospital Pharmacy
    • 7.3.2. Online Pharmacy
    • 7.3.3. Retail Pharmacy
    • 7.3.4. Clinics
  • 7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Human Growth Hormone Market Analysis and Forecast, by Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Indication, 2023-2031
    • 8.3.1. Growth Hormone Deficiency
    • 8.3.2. Turner Syndrome
    • 8.3.3. Idiopathic Short Stature
    • 8.3.4. Prader-Willi Syndrome
    • 8.3.5. Other Indications
  • 8.4. Market Attractiveness Analysis, by Indication

9. Global Human Growth Hormone Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2023-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Human Growth Hormone Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 10.3.1. Intravenous
    • 10.3.2. Subcutaneous
    • 10.3.3. Intramuscular
    • 10.3.4. Oral
  • 10.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 10.4.1. Hospital Pharmacy
    • 10.4.2. Online Pharmacy
    • 10.4.3. Retail Pharmacy
    • 10.4.4. Clinics
  • 10.5. Market Value Forecast, by Indication, 2023-2031
    • 10.5.1. Growth Hormone Deficiency
    • 10.5.2. Turner Syndrome
    • 10.5.3. Idiopathic Short Stature
    • 10.5.4. Prader-Willi Syndrome
    • 10.5.5. Other Indications
  • 10.6. Market Value Forecast, by Country, 2023-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Route of Administration
    • 10.7.2. By Distribution Channel
    • 10.7.3. By Indication
    • 10.7.4. By Country

11. Europe Human Growth Hormone Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 11.3.1. Intravenous
    • 11.3.2. Subcutaneous
    • 11.3.3. Intramuscular
    • 11.3.4. Oral
  • 11.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 11.4.1. Hospital Pharmacy
    • 11.4.2. Online Pharmacy
    • 11.4.3. Retail Pharmacy
    • 11.4.4. Clinics
  • 11.5. Market Value Forecast, by Indication, 2023-2031
    • 11.5.1. Growth Hormone Deficiency
    • 11.5.2. Turner Syndrome
    • 11.5.3. Idiopathic Short Stature
    • 11.5.4. Prader-Willi Syndrome
    • 11.5.5. Other Indications
  • 11.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Route of Administration
    • 11.7.2. By Distribution Channel
    • 11.7.3. By Indication
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Human Growth Hormone Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 12.3.1. Intravenous
    • 12.3.2. Subcutaneous
    • 12.3.3. Intramuscular
    • 12.3.4. Oral
  • 12.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 12.4.1. Hospital Pharmacy
    • 12.4.2. Online Pharmacy
    • 12.4.3. Retail Pharmacy
    • 12.4.4. Clinics
  • 12.5. Market Value Forecast, by Indication, 2023-2031
    • 12.5.1. Growth Hormone Deficiency
    • 12.5.2. Turner Syndrome
    • 12.5.3. Idiopathic Short Stature
    • 12.5.4. Prader-Willi Syndrome
    • 12.5.5. Other Indications
  • 12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Route of Administration
    • 12.7.2. By Distribution Channel
    • 12.7.3. By Indication
    • 12.7.4. By Country/Sub-region

13. Latin America Human Growth Hormone Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 13.3.1. Intravenous
    • 13.3.2. Subcutaneous
    • 13.3.3. Intramuscular
    • 13.3.4. Oral
  • 13.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 13.4.1. Hospital Pharmacy
    • 13.4.2. Online Pharmacy
    • 13.4.3. Retail Pharmacy
    • 13.4.4. Clinics
  • 13.5. Market Value Forecast, by Indication, 2023-2031
    • 13.5.1. Growth Hormone Deficiency
    • 13.5.2. Turner Syndrome
    • 13.5.3. Idiopathic Short Stature
    • 13.5.4. Prader-Willi Syndrome
    • 13.5.5. Other Indications
  • 13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Route of Administration
    • 13.7.2. By Distribution Channel
    • 13.7.3. By Indication
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Human Growth Hormone Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 14.3.1. Intravenous
    • 14.3.2. Subcutaneous
    • 14.3.3. Intramuscular
    • 14.3.4. Oral
  • 14.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 14.4.1. Hospital Pharmacy
    • 14.4.2. Online Pharmacy
    • 14.4.3. Retail Pharmacy
    • 14.4.4. Clinics
  • 14.5. Market Value Forecast, by Indication, 2023-2031
    • 14.5.1. Growth Hormone Deficiency
    • 14.5.2. Turner Syndrome
    • 14.5.3. Idiopathic Short Stature
    • 14.5.4. Prader-Willi Syndrome
    • 14.5.5. Other Indications
  • 14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Route of Administration
    • 14.7.2. By Distribution Channel
    • 14.7.3. By Indication
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Merck KGaA
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Eli Lilly and Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Pfizer Inc
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Novo Nordisk A/S
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Ipsen SA
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Roche Holdings, Inc
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Anhui Anke Biotechnology (Group) Co., Ltd.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Biopartners GmbH
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. GeneScience Pharmaceuticals Co., Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Novartis AG
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 02: Global Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 03: Global Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 04: Global Human Growth Hormone Market Size (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Human Growth Hormone Market Size (US$ Mn) Forecast, by Country, 2023-2031
  • Table 06: North America Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 07: North America Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 08: North America Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 09: Europe Human Growth Hormone Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Europe Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 11: Europe Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 12: Europe Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 13: Asia Pacific Human Growth Hormone Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 14: Asia Pacific Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 15: Asia Pacific Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 16: Asia Pacific Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 17: Latin America Human Growth Hormone Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 18: Latin America Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 19: Latin America Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 20: Latin America Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 21: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 23: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 24: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031

List of Figures

  • Figure 01: Global Human Growth Hormone Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Human Growth Hormone Market Revenue (US$ Mn), by Route of Administration, 2022
  • Figure 03: Global Human Growth Hormone Market Value Share, by Route of Administration, 2022
  • Figure 04: Global Human Growth Hormone Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 05: Global Human Growth Hormone Market Value Share, by Distribution Channel, 2022
  • Figure 06: Global Human Growth Hormone Market Revenue (US$ Mn), by Indication, 2022
  • Figure 07: Global Human Growth Hormone Market Value Share, by Indication, 2022
  • Figure 08: Global Human Growth Hormone Market Value Share, by Region, 2022
  • Figure 09: Global Human Growth Hormone Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 11: Global Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 12: Global Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 13: Global Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 14: Global Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 15: Global Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 16: Global Human Growth Hormone Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 17: Global Human Growth Hormone Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Human Growth Hormone Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 19: North America Human Growth Hormone Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Human Growth Hormone Market Value Share Analysis, by Country, 2023 and 2031
  • Figure 21: North America Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 22: North America Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 23: North America Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 24: North America Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 25: North America Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 26:North America Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 27: Europe Human Growth Hormone Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 28: Europe Human Growth Hormone Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Human Growth Hormone Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 30: Europe Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 31: Europe Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 32: Europe Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 33: Europe Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 34: Europe Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 35: Europe Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 36: Asia Pacific Human Growth Hormone Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 37: Asia Pacific Human Growth Hormone Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Human Growth Hormone Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Asia Pacific Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 40: Asia Pacific Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 41: Asia Pacific Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 42: Asia Pacific Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 43: Asia Pacific Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 44: Asia Pacific Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 45: Latin America Human Growth Hormone Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 46: Latin America Human Growth Hormone Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Human Growth Hormone Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Latin America Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 49: Latin America Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 50: Latin America Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 51: Latin America Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 52: Latin America Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 53: Latin America Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 54: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 55: Middle East & Africa Human Growth Hormone Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Human Growth Hormone Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 57: Middle East & Africa Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 58: Middle East & Africa Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 59: Middle East & Africa Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 60: Middle East & Africa Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 61: Middle East & Africa Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 62: Middle East & Africa Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031